Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells

por Kim, Kyu Kwang, Lange, Thilo S, Singh, Rakesh K, Brard, Laurent
Publicado 2010

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C

por Kim, Kyu Kwang, Lange, Thilo S, Singh, Rakesh K, Brard, Laurent, Moore, Richard G
Publicado 2012

Induction of cytotoxicity, apoptosis and cell cycle arrest by 1-t-butyl carbamoyl, 7-methyl-indole-3-ethyl isothiocyanate (NB7M) in nervous system cancer cells

por Brard, Laurent, Singh, Rakesh K, Kim, Kyu Kwang, Lange, Thilo S, Sholler, Giselle L Saulier
Publicado 2009

Organometallic Iron(III)-Salophene Exerts Cytotoxic Properties in Neuroblastoma Cells via MAPK Activation and ROS Generation

por Kim, Kyu Kwang, Singh, Rakesh K., Strongin, Robert M., Moore, Richard G., Brard, Laurent, Lange, Thilo S.
Publicado 2011

Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells

por Lange, Thilo S., Kim, Kyu Kwang, Singh, Rakesh K., Strongin, Robert M., McCourt, Carolyn K., Brard, Laurent
Publicado 2008

Correction: Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells

por Lange, Thilo S., Kim, Kyu Kwang, Singh, Rakesh K., Strongin, Robert M., McCourt, Carolyn K., Brard, Laurent
Publicado 2008

Role of trypsin and protease-activated receptor-2 in ovarian cancer

por Kim, Kyu Kwang, Turner, Rachael, Khazan, Negar, Kodza, Arif, Jones, Aaron, Singh, Rakesh K., Moore, Richard G.
Publicado 2020

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers

por Kim, Kyu Kwang, Han, Alex, Yano, Naohiro, Ribeiro, Jennifer R., Lokich, Elizabeth, Singh, Rakesh K., Moore, Richard G.
Publicado 2015

Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model

por Lange, Thilo S, McCourt, Carolyn, Singh, Rakesh K, Kim, Kyu Kwang, Singh, Ajay P, Luisi, Brian S, Alptürk, Onur, Strongin, Robert M, Brard, Laurent
Publicado 2009

Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer

por Rowswell-Turner, Rachael B., Rutishauser, Jennifer A., Kim, Kyu Kwang, Khazan, Negar, Sivagnanalingam, Umayal, Jones, Aaron M., Singh, Rakesh K., Moore, Richard G.
Publicado 2019

Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines

por Kim, Kyu Kwang, Singh, Rakesh K., Khazan, Negar, Kodza, Arif, Singh, Niloy A., Jones, Aaron, Sivagnanalingam, Umayal, Towner, Mary, Itamochi, Hiroaki, Turner, Rachael, Moore, Richard G.
Publicado 2020

Malignancy Assessment Using Gene Identification in Captured Cells Algorithm for the Prediction of Malignancy in Women With a Pelvic Mass

por Moore, Richard George, Khazan, Negar, Coulter, Madeline Ann, Singh, Rakesh, Miller, Michael Craig, Sivagnanalingam, Umayal, DuBeshter, Brent, Angel, Cynthia, Liu, Cici, Seto, Kelly, Englert, David, Meachem, Philip, Kim, Kyu Kwang
Publicado 2022

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth

por Moore, Richard G., Hill, Emily K., Horan, Timothy, Yano, Naohiro, Kim, KyuKwang, MacLaughlan, Shannon, Lambert-Messerlian, Geralyn, Tseng, YiTang Don, Padbury, James F., Miller, M. Craig, Lange, Thilo S., Singh, Rakesh K.
Publicado 2014

Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6

por James, Nicole E., Oliver, Matthew T., Ribeiro, Jennifer R., Cantillo, Evelyn, Rowswell-Turner, Rachael B., Kim, Kyu-Kwang, Chichester, Clinton O., DiSilvestro, Paul A., Moore, Richard G., Singh, Rakesh K., Yano, Naohiro, Zhao, Ting C.
Publicado 2019

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(®) PC1 System

por Cohen, Evan N., Jayachandran, Gitanjali, Moore, Richard G., Cristofanilli, Massimo, Lang, Julie E., Khoury, Joseph D., Press, Michael F., Kim, Kyu Kwang, Khazan, Negar, Zhang, Qiang, Zhang, Youbin, Kaur, Pushpinder, Guzman, Roberta, Miller, Michael C., Reuben, James M., Ueno, Naoto T.
Publicado 2022

Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo

por Khazan, Negar, Kim, Kyu Kwang, Hansen, Jeanne N., Singh, Niloy A., Moore, Taylor, Snyder, Cameron W. A., Pandita, Ravina, Strawderman, Myla, Fujihara, Michiko, Takamura, Yuta, Jian, Ye, Battaglia, Nicholas, Yano, Naohiro, Teramoto, Yuki, Arnold, Leggy A., Hopson, Russell, Kishor, Keshav, Nayak, Sneha, Ojha, Debasmita, Sharon, Ashoke, Ashton, John M., Wang, Jian, Milano, Michael T., Miyamoto, Hiroshi, Linehan, David C., Gerber, Scott A., Kawar, Nada, Singh, Ajay P., Tabdanov, Erdem D., Dokholyan, Nikolay V., Kakuta, Hiroki, Jurutka, Peter W., Schor, Nina F., Rowswell-Turner, Rachael B., Singh, Rakesh K., Moore, Richard G.
Publicado 2022

Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1

por Khazan, Negar, Quarato, Emily R., Singh, Niloy A., Snyder, Cameron W. A., Moore, Taylor, Miller, John P., Yasui, Masato, Teramoto, Yuki, Goto, Takuro, Reshi, Sabeeha, Hong, Jennifer, Zhang, Naixin, Pandey, Diya, Srivastava, Priyanka, Morell, Alexandra, Kawano, Hiroki, Kawano, Yuko, Conley, Thomas, Sahasrabudhe, Deepak M., Yano, Naohiro, Miyamoto, Hiroshi, Aljitawi, Omar, Liesveld, Jane, Becker, Michael W., Calvi, Laura M., Zhovmer, Alexander S., Tabdanov, Erdem D., Dokholyan, Nikolay V., Linehan, David C., Hansen, Jeanne N., Gerber, Scott A., Sharon, Ashoke, Khera, Manoj K., Jurutka, Peter W., Rochel, Natacha, Kim, Kyu Kwang, Rowswell-Turner, Rachael B., Singh, Rakesh K., Moore, Richard G.
Publicado 2023